Voluntary announcement strategic drug discovery collaboration between xtalpi subsidiary LCC technologies and stanford university
Filed with HKEX · Stock code 2228 · · 2 pages · English
XtalPi Holdings Limited晶泰控股有限公司 (Incorporated in the Cayman Islands with limited liability) (Stock Code: 2228) VOLUNTARY ANNOUNCEMENT STRATEGIC ## DRUG DISCOVERY COLLABORATION BETWEEN XTALPI ## SUBSIDIARY LCC TECHNOLOGIES AND STANFORD UNIVERSITY This announcement is made by XtalPi Holdings Limited (the “Company” or “XtalPi”, together with its subsidiaries, the “Group”) on a voluntary basis. The pu
XtalPi Holdings Limited on 6ix
Earlier from XtalPi
- XtalPi Holdings Limited to Announce 2026 Interim Results on August 19, 2026
- XtalPi Announces Strategic Partnership with a Leading Biopharma to Develop Oral Small Molecule Therapeutics for a GPCR Target
- XtalPi Receives Second Payment from DoveTree; First Oncology Asset Advances into IND-Enabling Studies
- XtalPi -Enabled PharmaEngine PEP08 Achieves Enrollment Milestone, with Second Synthetic Lethality Program Underway
- XtalPi Holdings Announces Full Year 2025 Annual Results
Later from XtalPi
- Voluntary announcement plan to increase shareholding in the company by the chairman of the board
- XtalPi AI Enables Seven-Month PCC Nomination for Viva-Thera's MPER-Targeting HIV-1 Program
- Grant of share options and restricted share units
- XtalPi Submits U.S. FDA IND Application for KQTD-126, a Potential First-in-Class, Gut-Restricted Pan-TRK Inhibitor for Chronic Intestinal Pain
- Next Day Disclosure Return
Follow XtalPi into a list and get an email when it puts out news.
Follow XtalPi